Related Experiment Videos
Replication-competent herpes simplex vectors: design and applications
R Argnani1, M Lufino, M Manservigi
1Department of Experimental and Diagnostic Medicine, Section of Microbiology, University of Ferrara, Ferrara, Italy.
Gene Therapy
|October 19, 2005
Summary
Genetically engineered herpes simplex virus (HSV) vectors, created by deleting nonessential genes, show promise for gene therapy and targeted cancer treatment. These attenuated viruses offer potential for diverse healthcare applications.
Area of Science:
- Virology
- Biotechnology
- Gene Therapy
Background:
- Replication-competent vectors are engineered from attenuated viruses with nonessential genes mutated or deleted.
- Gene deletion can reduce viral pathogenicity without needing cell line complementation for growth.
- Herpes simplex virus (HSV) is a versatile platform for various biomedical applications.
Purpose of the Study:
- To review the advancements in developing attenuated, genetically engineered HSV vectors.
- To highlight the potential of HSV vectors in human healthcare applications.
Main Methods:
- Review of existing literature on genetically engineered viral vectors.
- Focus on modifications of herpes simplex virus (HSV) for vector development.
Main Results:
- Genetically engineered HSV vectors can be created by altering nonessential genes.
- These vectors demonstrate potential for gene delivery to nervous system cells.
- HSV vectors show promise for selective cancer cell destruction and targeted infections.
Conclusions:
- Attenuated HSV vectors represent a significant advancement in vector technology.
- HSV vectors offer a wide range of potential therapeutic and prophylactic applications in human healthcare.